These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 31951925)

  • 1. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples.
    Green TC; Park JN; Gilbert M; McKenzie M; Struth E; Lucas R; Clarke W; Sherman SG
    Int J Drug Policy; 2020 Mar; 77():102661. PubMed ID: 31951925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.
    Sherman SG; Morales KB; Park JN; McKenzie M; Marshall BDL; Green TC
    Int J Drug Policy; 2019 Jun; 68():46-53. PubMed ID: 30991301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips.
    Lockwood TE; Vervoordt A; Lieberman M
    Harm Reduct J; 2021 Mar; 18(1):30. PubMed ID: 33750405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of rapid fentanyl test strips among young adults who use drugs.
    Krieger MS; Goedel WC; Buxton JA; Lysyshyn M; Bernstein E; Sherman SG; Rich JD; Hadland SE; Green TC; Marshall BDL
    Int J Drug Policy; 2018 Nov; 61():52-58. PubMed ID: 30344005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
    Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paper spray mass spectrometry: A new drug checking tool for harm reduction in the opioid overdose crisis.
    Vandergrift GW; Gill CG
    J Mass Spectrom; 2019 Sep; 54(9):729-737. PubMed ID: 31432563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a lateral flow chromatographic immunoassay for the detection of fentanyl in drug samples.
    Park JN; Sherman SG; Sigmund V; Breaud A; Martin K; Clarke WA
    Drug Alcohol Depend; 2022 Nov; 240():109610. PubMed ID: 36115223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting fentanyl using point-of-care drug checking technologies: A validation study.
    Ti L; Tobias S; Lysyshyn M; Laing R; Nosova E; Choi J; Arredondo J; McCrae K; Tupper K; Wood E
    Drug Alcohol Depend; 2020 Jul; 212():108006. PubMed ID: 32438280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the limit of detection of Fourier-transform infrared spectroscopy and immunoassay strips for fentanyl in a real-world setting.
    McCrae K; Tobias S; Grant C; Lysyshyn M; Laing R; Wood E; Ti L
    Drug Alcohol Rev; 2020 Jan; 39(1):98-102. PubMed ID: 31746056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals "blind spots" in detection capabilities.
    Hayes KL; Lieberman M
    Harm Reduct J; 2023 Dec; 20(1):175. PubMed ID: 38057832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Measurements of Codeine and Fentanyl on a Surface-Enhanced Raman-Active Pad Test.
    Shende C; Farquharson A; Brouillette C; Smith W; Farquharson S
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31315188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
    Borden SA; Saatchi A; Vandergrift GW; Palaty J; Lysyshyn M; Gill CG
    Drug Alcohol Rev; 2022 Feb; 41(2):410-418. PubMed ID: 34347332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.
    Swartz JA; Lieberman M; Jimenez AD; Mackesy-Amiti ME; Whitehead HD; Hayes KL; Taylor L; Prete E
    Harm Reduct J; 2023 Jul; 20(1):87. PubMed ID: 37420196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities.
    Morales KB; Park JN; Glick JL; Rouhani S; Green TC; Sherman SG
    Drug Alcohol Depend; 2019 Nov; 204():107547. PubMed ID: 31536877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costing analysis of a point-of-care drug checking program in Rhode Island.
    Cepeda JA; Thompson E; Ujeneza M; Tardif J; Walsh T; Morales A; Rosen JG; Green TC; Park JN
    Drug Alcohol Depend; 2023 Dec; 253():111028. PubMed ID: 38000322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug checking services at music festivals and events in a Canadian setting.
    McCrae K; Tobias S; Tupper K; Arredondo J; Henry B; Mema S; Wood E; Ti L
    Drug Alcohol Depend; 2019 Dec; 205():107589. PubMed ID: 31605958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive testing and rapid dissemination of local drug supply surveillance data in Rhode Island.
    Collins AB; Wightman RS; Macon EC; Guan Y; Shihipar A; Krieger M; Elmaleh R; Smith MC; Morales A; Badea A
    Int J Drug Policy; 2023 Aug; 118():104118. PubMed ID: 37422985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-Series Analysis of Fentanyl Concentration in the Unregulated Opioid Drug Supply in a Canadian Setting.
    Tobias S; Grant CJ; Laing R; Arredondo J; Lysyshyn M; Buxton J; Tupper KW; Wood E; Ti L
    Am J Epidemiol; 2022 Jan; 191(2):241-247. PubMed ID: 33977304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from a mobile drug checking pilot program using three technologies in Chicago, IL, USA.
    Karch L; Tobias S; Schmidt C; Doe-Simkins M; Carter N; Salisbury-Afshar E; Carlberg-Racich S
    Drug Alcohol Depend; 2021 Nov; 228():108976. PubMed ID: 34536717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.